Company / Interest Expense
Lipocine Inc. Interest Expense History
FY2020-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$27.1K
FY2023
5-year range
$27.1K / $386.6K
FY2020-FY2023
Trend
-86.7%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense has declined for 3 consecutive years, from $766,745 in FY2020 to $27,098 in FY2023.
Based on SEC 10-K filings.
$27,098 in FY2023 with a 3-year CAGR of -67.2%.
Improved from $386,618 to $27,098 over the past 2 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -67.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Lipocine Inc.'s interest expense has declined for 3 consecutive years.
- 3-year CAGR of -67.2%, indicating a declining trend.
- In FY2023, interest expense decreased 86.7% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.16 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $27.1K | -86.7% |
| FY2022 | $203.3K | -47.4% |
| FY2021 | $386.6K | -49.6% |
| FY2020 | $766.7K | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2013 | - | - |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026